首页> 外国专利> Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy

Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy

机译:用于确定受试者是否将从共受体抑制剂治疗中受益的组合物和方法

摘要

The present invention provides methods and compositions for determining whether a subject would benefit from co-receptor inhibitor therapy. In certain aspects, the methods can be used to determine whether a subject infected with a dual-mixed tropic population of HIV would benefit from CCCR5-inhibitor therapy or CXCR4-inhibitor therapy, the methods comprising determining whether the HIV population is a homogeneous or heterogeneous population of HIV, wherein the nature of the homogenous or heterogenous population of HIV indicates whether the patient would benefit from co-receptor inhibitor therapy.
机译:本发明提供了用于确定受试者是否将从共受体抑制剂治疗中受益的方法和组合物。在某些方面,该方法可用于确定感染HIV的热带双重混合感染的受试者是否将从CCCR5抑制剂治疗或CXCR4抑制剂治疗中受益,该方法包括确定HIV人群是同质的还是异质的HIV同种或异种HIV的种群的性质表明患者是否将从共受体抑制剂治疗中受益。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号